703 results found

On January 16, 2020, Indian Council of Medical Research announced a significant development that the WHO Global TB Programme has included an Indian Molecular assay...

In this episode of the Technology Podcast powered by INDIALAW LLP, host Riddhi Agarwal sits down with Appurv Bhatia—renowned compliance and privacy expert—to unpack the digital transformation...

The regulatory and quality control provisions for the manufacturing of Ayurvedic, Siddha and Unani drugs/ medicines, under the Drugs and Cosmetics Act, 1940, has expedited the process for granting the license.

On June 06, 2019, Directorate of Health Services, Kerala released the first of its kind interim guidelines on management of Nipah Virus (NiV) infection.

On March 28, 2019, the central government has amended the conditions for supply of sublingual tablets of Buprenorphine + Naloxone FDC and Buprenorphine alone.

On 9th March 2026, the Ministry of Health and Family Welfare, Government of India, published a significant draft amendment to the Drugs Rules, 1945, by way of Gazette Notification G.S.R. 164(E).

The Central Drugs Standard Control Organization (CDSCO), New Delhi, under the aegis of the Ministry of Health ...

On January 29, 2020, the Union Cabinet approved the Medical Termination of Pregnancy (Amendment) Bill, 2020, to amend the Medical Termination of Pregnancy Act, 1971.

The first dose may be given as early as 6 weeks of age.

In a first labour, it usually does not extend beyond 12 hours.

Insurance is a contract of indemnity based on the principle of utmost good faith which aims at mitigating the loss caused by an uncertain event such as life, health, fire, marine, etc.

Baricitinib is essentially a drug approved in the US and European Union, for the treatment of rheumatoid arthritis.

Since time immemorial, India has been one of the most preferred sources of procuring products for sale in the market worldwide.

Herbal medicine is considered as the medicine of the masses and is usually referred as ‘nature medicine’. The U.S. Food and Drug Administration (FDA) has for the first time approved a special extract of green tea as a prescription drug for the topical (external) treatment of genital warts caused by the human papilloma virus (HPV).

New anti-tobacco warning rules for OTTs issued by India's union health ministry for OTT platforms do not consider the unique nature of OTT content consumption.

The Union Budget 2024 represents a pivotal moment in India's economic journey. The new government has presented a detailed roadmap for India's burgeoning future that would further solidify India's position on the global stage.

With the rising need to accommodate the new requirements and adaptation of modern technology in the pharmaceutical sector, the draft of the ‘Drugs, Medical Devices and Cosmetics Bill, 2022'...

In the recent times the Indian pharma sector has been marked by dynamic changes. The Patent Act of 1970 as amended on March 22, 2005 marked the end of a protected era and has brought in a new phase in the integration of India into the global pharmaceutical market.